| Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence M Treskova-Schwarzbach, L Haas, S Reda, A Pilic, A Borodova, K Karimi, ... BMC medicine 19, 1-26, 2021 | 161 | 2021 |
| Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021 T Harder, J Koch, S Vygen-Bonnet, W Külper-Schiek, A Pilic, S Reda, ... Eurosurveillance 26 (28), 2100563, 2021 | 122 | 2021 |
| Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung S Vygen-Bonnet, J Koch, C Bogdan, T Harder, U Heininger, K Kling, ... Robert Koch-Institut, 2021 | 107 | 2021 |
| Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: the role of the progestogen type and estrogen dose C Oedingen, S Scholz, O Razum Thrombosis research 165, 68-78, 2018 | 78 | 2018 |
| Post-COVID-19-associated morbidity in children, adolescents, and adults: a matched cohort study including more than 157,000 individuals with COVID-19 in Germany M Roessler, F Tesch, M Batram, J Jacob, F Loser, O Weidinger, D Wende, ... PLoS medicine 19 (11), e1004122, 2022 | 67 | 2022 |
| Post COVID-19 in children, adolescents, and adults: results of a matched cohort study including more than 150,000 individuals with COVID-19 M Roessler, F Tesch, M Batram, J Jacob, F Loser, O Weidinger, D Wende, ... MedRxiv, 2021.10. 21.21265133, 2021 | 53 | 2021 |
| Beschluss und wissenschaftliche begründung der ständigen impfkommission (STIKO) für die COVID-19-impfempfehlung S Vygen-Bonnet, J Koch, C Bogdan, T Harder, U Heininger, K Kling, ... Robert Koch-Institut, 2020 | 52 | 2020 |
| Bevölkerung mit einem erhöhten Risiko für schwere COVID-19-Verläufe in Deutschland. Auswertungen der Studie GEDA 2019/2020-EHIS A Rommel, M Treskova-Schwarzbach, S Scholz, E von der Lippe Robert Koch-Institut, 2021 | 40* | 2021 |
| Epidemiology and cost of seasonal influenza in Germany-a claims data analysis S Scholz, O Damm, U Schneider, B Ultsch, O Wichmann, W Greiner BMC Public Health 19, 1-10, 2019 | 34 | 2019 |
| Individual social contact data and population mobility data as early markers of SARS-CoV-2 transmission dynamics during the first wave in Germany—an analysis based on the … DV Tomori, N Rübsamen, T Berger, S Scholz, J Walde, I Wittenberg, ... BMC medicine 19, 1-13, 2021 | 30 | 2021 |
| Welche Impfquote ist notwendig, um COVID-19 zu kontrollieren? O Wichmann, S Scholz, M Waize, N Schmid-Küpke, O Hamouda, ... Robert Koch-Institut, 2021 | 28 | 2021 |
| Kinder-und Jugendreport 2018 W Greiner, M Batram, O Damm, S Scholz, J Witte Beiträge zur Gesundheitsökonomie und Versorgungsforschung 23, 2018 | 27 | 2018 |
| Prerequisites for a new health care model for elderly people with multiple morbidities: results and conclusions from 3 years of research in the PRISCUS consortium U Thiem*, T Hinrichs*, CA Müller*, S Holt-Noreiks*, A Nagl*, C Bucchi, ... Zeitschrift für Gerontologie und Geriatrie 44, 101-112, 2011 | 27 | 2011 |
| Modeling rheumatoid arthritis using different techniques-a review of model construction and results S Scholz, T Mittendorf Health Economics Review 4, 1-16, 2014 | 26 | 2014 |
| The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany S Scholz, F Koerber, K Meszaros, RM Fassbender, B Ultsch, RR Welte, ... Vaccine 37 (12), 1692-1701, 2019 | 25 | 2019 |
| Applying sequence clustering techniques to explore practice-based ambulatory care pathways in insurance claims data V Vogt, SM Scholz, L Sundmacher The European Journal of Public Health 28 (2), 214-219, 2018 | 24 | 2018 |
| Die Zukunft der Pflege im Krankenhaus: Forschungsprojekt im Auftrag der Techniker Krankenkasse B Augurzky, C Bünnings, S Dördelmann, W Greiner, L Hein, S Scholz, ... RWI Materialien, 2016 | 24 | 2016 |
| Beschluss und Wissenschaftliche Begründung der Ständigen Impfkommission (STIKO) für die Aktualisierung der Influenza-Impfempfehlung für Personen im Alter von≥ 60 Jahren K Michaelis, S Scholz, S Buda, E Garbe, T Harder, T Ledig, M Terhardt, ... Robert Koch-Institut, 2020 | 23 | 2020 |
| Cost effectiveness of elderly pneumococcal vaccination in presence of higher-valent pneumococcal conjugate childhood vaccination: systematic literature review with focus on … M Treskova, SM Scholz, A Kuhlmann Pharmacoeconomics 37, 1093-1127, 2019 | 23 | 2019 |
| Quantifying Covid19-vaccine location strategies for Germany N Leithäuser, J Schneider, S Johann, SO Krumke, E Schmidt, M Streicher, ... BMC Health Services Research 21, 1-18, 2021 | 21 | 2021 |
